The best‐studied SNPs in NAFLD currently are rs738409 and rs58542926, which are located in PNPLA3 and TM6SF2, respectively.72 Both these biomarkers have impacts on the phenotypes and histological outcomes of NAFLD. This evidence concerns the gene TM6SF2 and metabolic dysfunction-associated steatotic liver disease.